Recombinant glycoprotein B vaccine formulation with Toll-like receptor 9 agonist and immune-stimulating complex induces specific immunity against multiple strains of cytomegalovirus. (Q53269265)
Jump to navigation
Jump to search
scientific article published on 9 February 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Recombinant glycoprotein B vaccine formulation with Toll-like receptor 9 agonist and immune-stimulating complex induces specific immunity against multiple strains of cytomegalovirus. |
scientific article published on 9 February 2011 |
Statements
Recombinant glycoprotein B vaccine formulation with Toll-like receptor 9 agonist and immune-stimulating complex induces specific immunity against multiple strains of cytomegalovirus. (English)
1 reference
1 reference
Vijayendra Dasari
1 reference
Corey Smith
1 reference
Jie Zhong
1 reference
Gillian Scott
1 reference
9 February 2011
1 reference
92
1 reference
Pt 5
1 reference
1021-1031
1 reference
Identifiers
1 reference